Postprocedural musculoskeletal disorders, not elsewhere classified

M13_POSTOPMUSCULOSKE

musculoskeletal system disease: A disease involving the musculoskeletal system. [database_cross_reference: MONDO:DesignPattern]

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M96 Hospital discharge: ICD-9 — 7228 Cause of death: ICD-10 — M96 Cause of death: ICD-9 — 7228 2 out of 7 registries used, show all original rules.	2523
4. Check minimum number of events None	2523
5. Include endpoints None	2523
6. Filter based on genotype QC (FinnGen only)	2523

Control definitions (FinnGen only)

Control exclude: M13_MUSCULOSKELEOTH

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M95-M99
Name in latin: Morbositates musculosceletales post interventiones non alibi classificati

NAME	M13_POSTOPMUSCULOSKE
CONTROL_EXCLUDE	M13_MUSCULOSKELEOTH
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M96
HD_ICD_9	7228
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M96
COD_ICD_9	7228
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Postprocedural musculoskeletal disorders, not elsewhere classified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	16616	9529	7003
Only index persons	15255	9021	6234
Unadjusted period prevalence (%)
Whole population	0.24	0.27	0.20
Only index persons	0.29	0.33	0.24
Median age at first event (years)
Whole population	60.08	63.04	56.06
Only index persons	59.85	62.69	55.74

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2523	1476	1047
Unadjusted period prevalence (%)	0.49	0.50	0.46
Median age at first event (years)	58.28	58.02	58.65

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2219: Matched controls
22189

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M96.6

ICD-10 Finland

Fracture of bone following insertion of orthopaedic implant, joint prosthesis, or bone plate

+∞

323.0

535

N03AX12

ATC

gabapentin; oral

7.3

323.0

943

2029

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

11326.0

323.0

766

M96.0

ICD-10 Finland

Pseudarthrosis after fusion or arthrodesis

6663.5

323.0

526

7228C

ICD-9 Finland

Intervertebral disk disorders, Postlaminectomy syndrome[SYNDROMA LUMBOSACRALE POSTLAMINECTOMIAM]

+∞

323.0

379

M48.0

ICD-10 Finland

Spinal stenosis

7.9

318.0

859

1646

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

7.2

301.9

882

1869

N02AX02

ATC

tramadol; systemic, rectal

5.1

275.0

1555

6957

N03AX16

ATC

pregabalin; oral

5.1

252.4

1071

3424

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

24.8

247.2

357

170

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

6.3

237.6

748

1661

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

11.1

237.0

484

546

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

13.9

207.9

374

318

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

6.6

204.0

595

1164

9211

FHL

Exploration or removal of diskusprolapse

17.5

193.5

315

208

M43.1

ICD-10 Finland

Spondylolisthesis

11.9

186.7

361

355

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

25.1

182.1

261

117

N02AA05

ATC

oxycodone; systemic

4.5

161.7

684

1984

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

6.4

157.7

463

884

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

15.4

156.6

267

195

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

9.9

152.3

324

376

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

11.2

147.5

293

298

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

22.2

147.3

219

109

M54.4

ICD-10 Finland

Lumbago with sciatica

4.1

144.9

678

2131

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

3.1

140.6

1360

7444

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

12.3

134.9

254

230

M16.1

ICD-10 Finland

Other primary coxarthrosis

4.5

134.8

552

1513

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.9

132.3

654

2132

N06AA09

ATC

amitriptyline; systemic

4.7

131.5

512

1330

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

40.6

131.4

166

B01AB05

ATC

enoxaparin; parenteral

3.1

130.7

1038

4868

NAU20

NOMESCO Finland

Removal of internal fixation device from spine or neck

101.1

129.7

142

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

4.8

126.4

480

1210

M96.8

ICD-10 Finland

Other postprocedural musculoskeletal disorders

+∞

125.2

119

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

10.9

119.2

238

241

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

41.0

115.9

146

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

7.6

111.0

276

406

NFJ62

NOMESCO Finland

Internal fixation of fracture of other parts of femur with plate

33.2

110.4

146

M54.5

ICD-10 Finland

Low back pain

2.9

107.8

960

4681

N06AX21

ATC

duloxetine; oral

4.3

107.8

452

1240

WX704

NOMESCO Finland

Intubation

5.2

105.4

359

792

TPH04

NOMESCO Finland

Cathetrisation of vein

3.1

103.8

721

2967

N02AJ06

ATC

codeine and paracetamol; systemic

2.7

100.6

1062

5668

ZZH31

NOMESCO Finland

Bone allograft, small pieces

23.8

100.2

145

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

4.9

98.9

354

821

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

13.1

98.5

179

148

N02BE01

ATC

paracetamol; systemic, rectal

4.5

98.2

2071

16805

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

6.8

97.7

263

431

SPAT1153

SPAT

Removal of sutures

2.7

97.2

996

5189

9212

FHL

Other posterior root decompression surgery (eg laminectomy, Gill)

30.6

96.5

130

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

4.5

95.6

377

965

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

7.9

95.1

229

318

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.7

94.1

355

868

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.6

90.0

896

4533

WX725

NOMESCO Finland

Noninvasive ventilation

6.2

89.9

258

459

NF1AA

NOMESCO Finland

Hip X-ray examination

4.1

89.8

398

1133

L03

ICPC

Low back symptom/complaint

2.8

88.9

740

3361

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

4.9

88.7

314

715

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

4.6

88.5

339

838

WX320

NOMESCO Finland

Spinalanesthesy

2.8

88.5

721

3229

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

25.5

86.9

123

L86

ICPC

Back syndrome with radiating pain

5.2

85.9

290

626

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

7.8

84.9

205

285

NE1AA

NOMESCO Finland

Pelvis X-ray examination

4.6

83.6

317

773

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.7

81.5

409

1287

N02AC04

ATC

dextropropoxyphene; oral

6.3

81.4

230

399

S18

ICPC

Laceration/cut

2.4

81.4

1157

6967

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

7.0

80.5

209

323

M19.0

ICD-10 Finland

Primary arthrosis of other joints

3.7

79.0

395

1237

NAG65

NOMESCO Finland

Anterior and posterior fusion of lumbar spine

41.0

78.0

M01AH05

ATC

etoricoxib; oral

2.3

76.7

1466

10083

WX702

NOMESCO Finland

Supraglottic ventilation device

5.3

75.9

249

517

NF3AA

NOMESCO Finland

Femur X-ray examination

10.9

75.3

149

146

72510

ICD-8 Finland

Displacement of intervertebral disk, Lumbalis cum prolapsu disci

8.2

75.1

175

229

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

10.5

75.0

151

153

NFJ64

NOMESCO Finland

Other internal fixation of fracture of other parts of femur

67.9

73.9

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.9

73.3

520

2093

M79.6

ICD-10 Finland

Pain in limb

2.3

72.8

976

5600

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

5.6

72.0

223

432

S72.3

ICD-10 Finland

Fracture of shaft of femur

21.0

72.0

108

WX408

NOMESCO Finland

General anesthesy, balanced

2.5

71.6

777

3995

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.8

70.6

554

2368

TPH07

NOMESCO Finland

Cathetrisation of artery

3.4

70.1

389

1312

M43.0

ICD-10 Finland

Spondylolysis

10.8

68.8

136

133

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

10.3

68.5

139

143

X59

ICD-10 Finland

Exposure to unspecified factor

2.7

68.1

551

2391

WX212

NOMESCO Finland

Femoral plexus blockade

9.3

66.8

144

165

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

3.1

66.6

416

1524

ZXA05

NOMESCO Finland

Left side

2.4

65.7

757

3977

N03AE01

ATC

clonazepam; systemic

4.5

65.6

251

611

L13

ICPC

Hip symptom/complaint

2.7

65.5

526

2266

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.4

63.4

658

3264

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.3

63.3

833

4650

M01AE03

ATC

ketoprofen; systemic, rectal

2.2

63.2

1021

6255

M54.3

ICD-10 Finland

Sciatica

4.1

62.9

263

697

M96.9

ICD-10 Finland

Postprocedural musculoskeletal disorder, unspecified

+∞

61.7

M01AH01

ATC

celecoxib; oral (coxibs)

2.5

61.3

573

2679

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

3.1

60.6

380

1387

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

10.8

60.3

119

116

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

7.6

60.2

147

206

M03BX02

ATC

tizanidine; oral

2.1

60.0

1448

10438

M54.1

ICD-10 Finland

Radiculopathy

5.2

59.6

195

401

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.1

58.5

987

6097

M47.9

ICD-10 Finland

Spondylosis, unspecified

5.8

58.4

174

320

A02BC02

ATC

pantoprazole; systemic

2.1

58.2

1579

11879

WX720

NOMESCO Finland

Own respiration

5.1

58.2

193

403

L17

ICPC

Foot/toe symptom/complaint

2.3

58.0

696

3681

ZXA00

NOMESCO Finland

Right side

2.2

58.0

777

4329

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

4.5

57.7

221

537

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

4.2

56.5

230

592

L28

ICPC

Limited function/disability (L)

2.5

53.8

481

2174

WX400

NOMESCO Finland

Inhalation anesthesy

5.3

53.7

174

353

H02AB06

ATC

prednisolone; systemic

2.0

53.7

1152

7751

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

23.8

53.0

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

9.4

52.7

112

125

SPAT1301

SPAT

No procedures

2.1

52.7

838

4981

A02BC03

ATC

lansoprazole; oral

2.1

52.5

794

4620

N05CF01

ATC

zopiclone; oral

2.1

51.6

851

5127

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

4.8

51.0

178

392

M54.9

ICD-10 Finland

Dorsalgia, unspecified

3.0

50.8

335

1254

WX002

NOMESCO Finland

Sedation and analgesia

2.3

50.1

569

2895

M01AC06

ATC

meloxicam; systemic, rectal

2.0

50.0

943

5975

J01DB01

ATC

cefalexin; oral

2.2

49.8

1834

15083

7240B

ICD-9 Finland

Other and unspecified disorders of back, Spinal stenosis, other than cervical[STENOSIS CANALIS SPINALIS LUMBOSACRALIS]

16.1

49.5

M75.1

ICD-10 Finland

Rotator cuff syndrome

2.2

49.0

652

3564

R52.2

ICD-10 Finland

Other chronic pain

5.5

49.0

151

289

A02BC05

ATC

esomeprazole; systemic

2.0

48.5

1021

6719

9183

FHL

Posterolateral spondylodesis

106.4

48.0

M47.82

ICD-10 Finland

Other spondylosis, cervical region

4.6

47.8

176

409

N06AX11

ATC

mirtazapine; oral

2.0

47.7

801

4819

NH1FA

NOMESCO Finland

Weight-bearing X-ray of ankle

15.1

47.1

M20.1

ICD-10 Finland

Hallux valgus (acquired)

3.0

47.0

298

1083

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

4.2

46.9

189

480

NHG22

NOMESCO Finland

Fusion of subtalar joint

20.6

46.8

X58

ICD-10 Finland

Exposure to other specified factors

2.6

46.2

370

1558

7221A

ICD-9 Finland

Intervertebral disk disorders, Displacement of thoracic or lumbar intervertebral disk without myelopathy

17.0

46.2

SPAT1229

SPAT

Assessment of need for aid

3.1

46.1

281

995

J01FF01

ATC

clindamycin; systemic

2.1

46.1

701

4038

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

3.3

46.0

249

810

M03BC01

ATC

orphenadrine (citrate); systemic

2.2

46.0

584

3109

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.5

45.9

424

1932

NHL14

NOMESCO Finland

Shortening or lengthening of achilles tendon

19.5

45.9

WX214

NOMESCO Finland

Plexus blockade at the ankle

22.2

45.9

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

6.1

45.4

128

219

SAA02

NOMESCO Finland

Basic examination of mouth

1.9

45.2

1366

10151

M01AB05

ATC

diclofenac; systemic, rectal

1.9

44.9

1527

11826

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

8.7

44.9

118

WX110

NOMESCO Finland

Local anesthesy

1.9

44.8

1506

11609

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

15.6

44.7

M01AB51

ATC

indometacin, combinations; oral, rectal

6.1

44.5

126

217

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

4.2

44.0

179

458

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.4

43.8

427

1997

Y83.1

ICD-10 Finland

Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

8.7

43.4

115

A28

ICPC

Limited function/disability NOS

2.3

42.8

442

2125

SPAT1263

SPAT

Sampling

1.9

42.8

1019

6905

TAB20

NOMESCO Finland

Epidural puncture

11.7

42.0

M01AH02

ATC

rofecoxib; oral

2.4

42.0

414

1943

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

42.0

570

3108

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

3.4

41.1

219

702

M67.0

ICD-10 Finland

Short Achilles tendon (acquired)

17.1

40.8

M53.2

ICD-10 Finland

Spinal instabilities

12.1

40.1

RF210

NOMESCO Finland

5.4

40.1

125

242

AA1AD

NOMESCO Finland

CT of head and brain

2.0

40.1

620

3556

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

5.1

39.8

130

266

NF1DA

NOMESCO Finland

X-ray of hips

5.7

39.7

118

216

C03CA01

ATC

furosemide; systemic

1.9

39.6

733

4501

A06AD11

ATC

lactulose; oral

2.3

39.3

406

1945

NHG20

NOMESCO Finland

Fusion of talocrural joint

14.7

39.1

NAG67

NOMESCO Finland

Posterior interbody fusion of lumbar spine, more than 2 vertebrae

139.1

38.8

WZA90

NOMESCO Finland

Other doctors statement

2.1

38.8

563

3137

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

38.4

803

5141

ZZH40

NOMESCO Finland

Substitute of bone

10.5

38.3

WX402

NOMESCO Finland

General anaesthesia

2.3

38.2

421

2076

M01AX17

ATC

nimesulide; oral

2.0

38.1

655

3901

NFU20

NOMESCO Finland

Removal of internal fixation device from femur

11.1

37.9

M01AB55

ATC

diclofenac, combinations; oral

2.9

37.7

245

901

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

4.0

37.7

158

415

L15

ICPC

Knee symptom/complaint

2.1

37.5

542

3007

N06AX16

ATC

venlafaxine; oral

2.5

37.5

339

1513

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.3

37.3

379

1796

NGC30

NOMESCO Finland

Secondary implantation of prosthesis in knee joint, special prosthesis

13.7

36.8

M25.5

ICD-10 Finland

Pain in joint

1.9

36.7

674

4101

A02BC01

ATC

omeprazole; systemic

1.9

36.5

701

4332

N05BA01

ATC

diazepam; systemic, rectal

2.3

36.3

380

1825

N07BC02

ATC

methadone; systemic

30.6

36.1

NH3EA

NOMESCO Finland

Feet X-ray examination with load

6.0

35.8

102

177

R52.1

ICD-10 Finland

Chronic intractable pain

11.9

35.6

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.9

35.6

231

847

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

18.2

35.4

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

4.0

35.4

149

393

J01MA02

ATC

ciprofloxacin; systemic

1.8

35.4

925

6331

NFH30

NOMESCO Finland

Reduction of dislocation prosthesis of hip joint, closed

15.6

35.3

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.5

35.0

171

511

NF3BA

NOMESCO Finland

Femur extensive X-ray examination

25.0

35.0

J45.9

ICD-10 Finland

Asthma, unspecified

2.1

34.8

456

2421

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

34.5

1040

7423

M01AE02

ATC

naproxen; oral, rectal

1.7

34.3

1240

9354

WX306

NOMESCO Finland

Lumbar epidural anesthesy

3.7

34.2

158

451

WZA00

NOMESCO Finland

Short statement of of health and health related matters

3.3

34.2

183

587

J01DA01

ATC

[U] cefalexin; systemic

1.7

34.1

1394

10912

L08

ICPC

Shoulder symptom/complaint

2.0

34.0

501

2790

NAG60

NOMESCO Finland

Anterior fusion of lumbar spine with fixation

121.9

33.8

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.8

33.6

728

4664

M70.6

ICD-10 Finland

Trochanteric bursitis

2.3

33.6

344

1630

N06AA10

ATC

nortriptyline; systemic

5.7

33.5

180

XA402

NOMESCO Finland

ENMG

5.0

33.3

110

228

72880

ICD-8 Finland

Vertebrogenic pain syndrome, Radicula syndrome of lower limbs

6.9

33.1

125

NH1AD

NOMESCO Finland

Ankle and foot CT

6.0

32.8

161

WX308

NOMESCO Finland

Sacral anesthesy

18.0

32.8

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.4

32.5

316

1457

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

6.6

32.3

133

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.2

32.0

377

1903

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

31.7

817

5513

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

4.0

31.7

133

350

N05CD07

ATC

temazepam; oral

2.2

31.6

349

1708

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

31.6

1453

11633

M01AH03

ATC

valdecoxib; oral

2.9

31.5

209

777

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.8

31.4

219

838

T84.2

ICD-10 Finland

Mechanical complication of internal fixation device of other bones

53.7

31.3

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.7

31.3

234

936

S72.2

ICD-10 Finland

Subtrochanteric fracture

10.6

31.2

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

4.6

31.0

112

255

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.7

31.0

975

6975

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.0

31.0

434

2356

M01AX05

ATC

glucosamine; oral

1.9

30.7

555

3319

NAG53

NOMESCO Finland

Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea

47.0

30.6

J04AB02

ATC

rifampicin; systemic

7.7

30.6

SPAT1260

SPAT

Consultation of another employee

2.0

30.5

462

2585

NH1EA

NOMESCO Finland

Ankle X-ray examination with load or wrench

18.4

30.5

-1

NOMESCO Finland

1.8

30.3

687

4434

A01

ICPC

Pain general/multiple sites

2.7

30.2

224

890

SAA03

NOMESCO Finland

Extended examination of mouth

1.7

30.1

810

5512

NHG26

NOMESCO Finland

Fusion between bones of ankle or ankle and foot

8.4

30.1

M01AX01

ATC

nabumetone; oral

3.4

29.9

155

485

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.7

29.8

1167

8851

NFC00

NOMESCO Finland

Exchange of a loose part of prosthesis in hip joint

17.1

29.7

M41.9

ICD-10 Finland

Scoliosis, unspecified

6.9

29.6

112

R06.0

ICD-10 Finland

Dyspnoea

1.8

29.5

592

3663

M01AE01

ATC

ibuprofen; systemic, rectal

2.0

29.4

1931

17088

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.7

29.3

214

840

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

3.3

29.1

155

495

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

4.0

29.1

122

321

ZSN00

NOMESCO Finland

Procedure related to previous procedure classified in chapter N

13.8

29.0

R51.80

ICD-10 Finland

Headache

2.2

29.0

332

1649

SPAT1216

SPAT

Assessment of functional ability

2.0

29.0

405

2191

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

5.2

28.8

184

S72.0

ICD-10 Finland

Fracture of neck of femur

3.7

28.7

130

365

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

7.5

28.5

9294

FHL

Endoprosthesis replacement of the entire hip joint (eg Charnley)

10.1

28.5

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

5.0

28.2

193

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

4.7

27.9

217

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.8

27.8

606

3840

S72.4

ICD-10 Finland

Fracture of lower end of femur

9.9

27.7

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

3.0

27.7

170

600

S72.1

ICD-10 Finland

Pertrochanteric fracture

5.2

27.5

172

SPAT1262

SPAT

Handing over of treatment supplies

1.9

27.5

456

2631

RD211

NOMESCO Finland

3.3

27.4

142

444

B01AB04

ATC

dalteparin; parenteral

3.0

27.1

162

562

AEA24

NOMESCO Finland

Removal of spinal stimulation elecrode

24.1

27.0

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.2

27.0

287

1376

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

3.1

26.9

152

506

SPAT1254

SPAT

Administration of medicine

2.1

26.9

361

1914

Z98.1

ICD-10 Finland

Arthrodesis status

76.1

26.8

SPAT1310

SPAT

Counselling related to known health issue

1.7

26.6

728

4935

NAG61

NOMESCO Finland

Posterior fusion of lumbar spine without fixation

19.4

26.5

NAK30

NOMESCO Finland

Osteotomy of spine

46.3

26.5

N05AH04

ATC

quetiapine; oral

2.1

26.4

352

1862

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

26.3

497

2996

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.1

26.3

331

1707

N03AX09

ATC

lamotrigine; oral

3.5

26.3

127

377

7225B

ICD-9 Finland

Intervertebral disk disorders, Degeneration of thoracic or lumbar intervertebral disk[DEGEN DISCI INTERVERT THORAC SEU LUMBOSACR CUM INST]

17.4

26.2

NHL68

NOMESCO Finland

Tenodesis, shortening or lengthening of tendon of foot

6.3

26.0

114

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.7

25.9

188

736

W19

ICD-10 Finland

Unspecified fall

2.4

25.6

241

1086

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

10.9

25.6

WW502

NOMESCO Finland

Autotransfusion

12.3

25.5

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

25.5

644

4250

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

4.5

25.3

207

NFC40

NOMESCO Finland

Repair of hip prosthesis by bone transplant to acetabulum

12.4

25.0

ABA99

NOMESCO Finland

Other diagnostic operation on spinal cord or nerve root

+∞

25.0

S72.9

ICD-10 Finland

Fracture of femur, part unspecified

17.2

24.9

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

11.1

24.9

ACC51

NOMESCO Finland

Release of median nerve

2.5

24.9

215

927

L88

ICPC

Rheumatoid/seropositive arthritis

3.4

24.6

125

386

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.7

24.5

596

3879

R03AC02

ATC

salbutamol; inhalant

1.6

24.3

1106

8532

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.6

24.2

184

738

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.6

24.1

1083

8327

N06AB04

ATC

citalopram; systemic

1.8

23.9

484

2972

J01EA01

ATC

trimethoprim; systemic

1.7

23.9

588

3838

R60.0

ICD-10 Finland

Localized oedema

2.1

23.9

286

1441

L04AA13

ATC

leflunomide; oral

3.9

23.8

100

264

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

3.4

23.7

120

369

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.0

23.7

245

L89

ICPC

Osteoarthrosis of hip

3.3

23.7

124

391

NG1DA

NOMESCO Finland

X-ray of knees

4.8

23.7

175

RF220

NOMESCO Finland

5.9

23.6

117

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

7.7

23.6

T84.1

ICD-10 Finland

Mechanical complication of internal fixation device of bones of limb

10.4

23.6

M84.1

ICD-10 Finland

Nonunion of fracture [pseudarthrosis]

9.6

23.5

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.7

23.5

169

657

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

3.8

23.4

101

273

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

8.9

23.1

S73.0

ICD-10 Finland

Dislocation of hip

11.9

23.0

A02BA02

ATC

ranitidine; systemic

1.8

22.8

488

3044

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.1

22.8

130

436

N04BC05

ATC

pramipexole; oral

2.4

22.6

207

921

M19.2

ICD-10 Finland

Other secondary arthrosis

6.7

22.6

B01AX06

ATC

[U] rivaroxaban; oral

4.0

22.4

233

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.4

22.4

208

929

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

8.2

22.4

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.3

22.4

119

380

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.5

22.4

109

326

W00

ICD-10 Finland

Fall on same level involving ice and snow

2.1

22.4

266

1334

M02AA07

ATC

piroxicam; topical

1.6

22.3

840

6136

WX213

NOMESCO Finland

Lower leg blockade

10.2

22.3

G83.4

ICD-10 Finland

Cauda equina syndrome

16.9

22.3

B01AF01

ATC

rivaroxaban; oral

2.0

22.2

314

1692

S72.8

ICD-10 Finland

Fractures of other parts of femur

18.1

22.2

L75

ICPC

Fracture: femur

5.9

21.6

106

J01MA12

ATC

levofloxacin; systemic

1.8

21.6

423

2559

NAG99

NOMESCO Finland

Other excision, reconstruction or fusion of joints of spine, unspecified

116.1

21.6

7151E

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, LONKKANIVEL]

9.2

21.6

KMAK

NOMESCO Finland

1.5

21.4

1018

7844

AEA20

NOMESCO Finland

Removal of impulse generator of stimulation device in the nervous system

43.8

21.4

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

3.7

21.4

269

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.2

21.3

242

1191

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.7

21.1

543

3568

N05BA04

ATC

oxazepam; oral

1.7

21.1

543

3571

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

21.1

514

3327

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.1

21.0

119

396

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.6

21.0

159

639

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

5.2

21.0

131

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.5

20.9

179

765

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

20.9

1320

10838

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.1

20.9

270

1401

K02.1

ICD-10 Finland

Caries of dentine

1.5

20.9

1103

8692

S70.0

ICD-10 Finland

Contusion of hip

3.3

20.8

108

339

R05

ICPC

Cough

1.7

20.7

481

3065

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.7

20.6

145

556

NF3AD

NOMESCO Finland

Femur CT

42.1

20.5

Y88.1

ICD-10 Finland

Sequelae of misadventures to patients during surgical and medical procedures

6.1

20.4

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.2

20.4

194

Z50.1

ICD-10 Finland

Other physical therapy

2.6

20.4

159

649

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

20.4

660

4614

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

20.3

361

2113

SPAT1202

SPAT

Intra-articular injection

3.2

20.2

111

364

L12

ICPC

Hand/finger symptom/complaint

1.9

20.2

311

1730

P01BA02

ATC

hydroxychloroquine; oral

2.2

20.1

217

1041

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.3

20.1

205

957

72870

ICD-8 Finland

Vertebrogenic pain syndrome, Lumbalgia

6.4

20.0

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

3.0

20.0

120

416

M54.2

ICD-10 Finland

Cervicalgia

2.4

20.0

176

764

S15

ICPC

Foreign body in skin

2.5

19.9

167

707

TAC99

NOMESCO Finland

Other blockade for chronic pain

8.1

19.7

NHG24

NOMESCO Finland

Fusion of subtalar joint and between bones of ankle

8.1

19.7

S97

ICPC

Chronic ulcer skin

2.6

19.7

150

602

NG1AD

NOMESCO Finland

Knee CT examination

5.4

19.7

111

R02

ICPC

Shortness of breath/dyspnoea

2.0

19.7

277

1487

ABD99

NOMESCO Finland

Other operation on spinal cord or nerve for pain or impaired function

16.5

19.6

NAT20

NOMESCO Finland

Reinsertion and tuning of internal fixation device

106.0

19.6

UKC02

NOMESCO Finland

Cystoscopy

1.8

19.5

378

2272

M13.9

ICD-10 Finland

Arthritis, unspecified

2.4

19.5

176

776

35399

ICD-8 Finland

Sciatica

6.4

19.5

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.4

19.4

170

738

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

3.8

19.4

229

NHG82

NOMESCO Finland

Fusion of other tarsal joint

5.9

19.4

M51.2

ICD-10 Finland

Other specified intervertebral disc displacement

9.2

19.3

SPAT1240

SPAT

Therapeutic discussion

2.2

19.3

203

964

R06AE07

ATC

cetirizine; oral

1.5

19.2

884

6702

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

5.6

19.2

102

RF421

NOMESCO Finland

11.1

19.2

L16

ICPC

Ankle symptom/complaint

2.1

19.2

233

1178

ZZH22

NOMESCO Finland

Graft of patients own bone, block

10.4

19.1

WX290

NOMESCO Finland

Other blockade of nerve

1.5

19.1

789

5832

XKC03

NOMESCO Finland

Water cystometry

3.3

19.0

313

M01AE51

ATC

ibuprofen, combinations; systemic

4.3

18.9

165

M54.8

ICD-10 Finland

Other dorsalgia

3.0

18.9

114

398

ZXC95

NOMESCO Finland

Use of surgical navigator

6.5

18.9

NHK40

NOMESCO Finland

Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone

4.4

18.8

157

7245A

ICD-9 Finland

Other and unspecified disorders of back, Backache, unspecified

6.1

18.8

R35

ICD-10 Finland

Polyuria

2.4

18.8

163

704

P01AB01

ATC

metronidazole; oral, rectal

1.5

18.8

827

6199

RF420

NOMESCO Finland

5.6

18.7

101

SPAT1255

SPAT

Intravenous administration of medicine

2.3

18.7

177

799

ABC99

NOMESCO Finland

Other decompressive operation on spinal cord or nerve root

28.1

18.7

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

18.7

949

7344

A46

ICD-10 Finland

Erysipelas

1.8

18.6

332

1938

RF120

NOMESCO Finland

5.7

18.6

C07AB07

ATC

bisoprolol; oral

1.5

18.5

1053

8344

Z71.8

ICD-10 Finland

Other specified counselling

1.7

18.5

474

3098

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

18.5

589

4078

N06AB03

ATC

fluoxetine; oral

1.9

18.4

286

1588

NHL99

NOMESCO Finland

Other operation on muscle or tendon of ankle or foot

8.5

18.4

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.2

18.4

100

326

J01XX08

ATC

linezolid; systemic

10.1

18.4

A07EC01

ATC

sulfasalazine; oral, rectal

2.2

18.4

194

923

L02

ICPC

Back symptom/complaint

2.2

18.4

205

998

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.6

18.3

140

566

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.6

18.3

135

533

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

8.0

18.3

J01FA06

ATC

roxithromycin; oral

1.5

18.2

853

6469

S54

ICPC

Skin, Repair/fix-suture/cast/prosth device

3.3

18.2

290

N06AX03

ATC

mianserin; oral

2.6

18.2

138

555

L90

ICPC

Osteoarthrosis of knee

2.3

18.1

170

764

NH1AI

NOMESCO Finland

Cone beam CT of ankle

14.5

18.1

G04BD12

ATC

mirabegron; oral

2.0

18.0

255

1371

NFU00

NOMESCO Finland

Removal of partial prosthesis from hip joint, other or unspecified

33.2

18.0

R33

ICD-10 Finland

Retention of urine

2.2

18.0

186

875

2309

FHL

Other measure in this category

52.9

18.0

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

17.8

308

1779

J01CA04

ATC

amoxicillin; systemic

1.5

17.7

1653

14516

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.7

17.7

124

475

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.4

17.7

157

688

G04CA02

ATC

tamsulosin; oral

1.7

17.6

467

3073

R96

ICPC

Asthma

2.1

17.5

211

1063

NA8CB

NOMESCO Finland

Discography with X-ray

181.3

17.5

G56.4

ICD-10 Finland

Causalgia

13.2

17.4

TAD08

NOMESCO Finland

Sympathetic block on sacral Level

29.0

17.4

N02AJ13

ATC

tramadol and paracetamol; systemic

4.0

17.3

180

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

17.3

688

5013

7214A

ICD-9 Finland

Spondylosis and allied disorders, Thoracic or lumbar spondylosis with myelopathy

21.0

17.3

NA7BT

NOMESCO Finland

Injection to spinal facet joint with radiological guidance

14.0

17.3

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

17.2

202

1006

EBA00

NOMESCO Finland

Extraction of tooth

1.6

17.2

641

4599

AN2

Balloon angioplasty, including several vessels

3.2

17.2

297

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

3.0

17.2

103

357

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.1

17.1

216

1107

M09AX01

ATC

hyaluronic acid; parenteral

2.4

17.1

144

612

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.3

17.1

168

770

N02BE51

ATC

paracetamol, combinations excl. psycholeptics; systemic

5.4

16.9

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

5.5

16.9

SPAT1097

SPAT

Recording of ECG

1.7

16.9

358

2207

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

3.7

16.8

210

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.7

16.8

119

459

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

16.8

393

2494

M79.7

ICD-10 Finland

Fibromyalgia

3.1

16.8

302

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

16.8

1014

8080

7384A

ICD-9 Finland

Other acquired deformity, Acquired spondylolisthesis

+∞

16.7

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.4

16.7

238

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.8

16.6

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

4.6

16.4

127

M01CB01

ATC

sodium aurothiomalate; parenteral

4.6

16.4

127

N03A

ATC

ANTIEPILEPTICS

20.2

16.4

M41.5

ICD-10 Finland

Other secondary scoliosis

20.2

16.4

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

3.3

16.4

263

Z01.2

ICD-10 Finland

Dental examination

1.5

16.3

787

5971

J01AA02

ATC

doxycycline; systemic

1.5

16.3

1682

14925

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

16.1

377

2388

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.2

16.1

171

816

N03AF01

ATC

carbamazepine; oral, rectal

2.4

16.0

135

576

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

16.0

311

1863

L99

ICPC

Musculoskeletal disease other

4.0

16.0

159

ZZH20

NOMESCO Finland

Graft of patients own bone

9.5

15.9

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.3

15.9

150

677

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

15.8

258

1458

M48.9

ICD-10 Finland

Spondylopathy, unspecified

8.1

15.8

G56.2

ICD-10 Finland

Lesion of ulnar nerve

3.1

15.8

303

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

15.8

629

4567

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

15.7

412

2696

P03

ICPC

Feeling depressed

2.2

15.6

158

737

NFC30

NOMESCO Finland

Repair of hip prosthesis by bone transplant to femur

22.2

15.5

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

15.5

285

1678

R42

ICD-10 Finland

Dizziness and giddiness

1.6

15.5

481

3290

NDG30

NOMESCO Finland

Fusion of wrist, total

9.0

15.4

NBB20

NOMESCO Finland

Primary total prosthetic replacement of humero-scapular joint

5.5

15.4

N06AA12

ATC

doxepin; systemic

2.3

15.4

141

626

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.4

15.4

1099

8992

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

3.6

15.3

191

S06.0

ICD-10 Finland

Concussion

2.0

15.2

210

1115

75618

ICD-8 Finland

Other congenital anomalies of musculoskeletal system, Maleformationes columnae vertebralis aliae

16.2

15.2

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.9

15.2

229

1260

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.3

15.1

235

R60.9

ICD-10 Finland

Oedema, unspecified

2.5

15.1

125

526

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

2.5

15.1

117

478

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

3.5

15.0

205

D07AC01

ATC

betamethasone; topical

1.5

14.9

718

5417

M03BX01

ATC

baclofen; systemic

4.2

14.8

136

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

3.5

14.8

196

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.6

14.8

111

445

Y96.9

ICD-10 Finland

Unspecified type of accident

3.9

14.8

156

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

14.7

535

3791

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.0

14.7

188

971

N05CF02

ATC

zolpidem; oral

1.6

14.7

383

2499

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

3.9

14.7

157

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.0

14.7

185

948

NA2AD

NOMESCO Finland

Thoracic spine CT examination

7.8

14.6

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.5

14.6

738

5620

Y88

ICD-10 Finland

Sequelae with surgical and medical care as external cause

7.1

14.6

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

4.4

14.5

120

M20.2

ICD-10 Finland

Hallux rigidus

2.9

14.5

323

M41.8

ICD-10 Finland

Other forms of scoliosis

8.9

14.4

N05AA02

ATC

levomepromazine; systemic

2.7

14.4

102

395

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

14.4

807

6270

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.3

14.4

138

629

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1672

10109

2.94

141.25

5.9

4.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

418

1207

3.95

126.47

9.2

10.1

—

(3042936) Bacteria identified in Isolate by Culture

746

3116

2.98

124.42

3.2

2.0

—

(3047181) Lactate [Moles/volume] in Blood

302

695

4.80

123.02

7.4

6.5

mmol/l

1.2

1.3

1.99

272

609

(3002173) Hemoglobin [Mass/volume] in Arterial blood

586

2155

3.24

121.78

8.4

8.0

g/l

116.6

120.9

5.53

545

2076

(3018572) Chloride [Moles/volume] in Blood

249

493

5.49

120.72

7.8

7.5

mmol/l

105.3

105.2

0.13

222

441

(3039000) Anion gap in Blood

249

493

5.49

120.72

7.8

7.5

mmol/l

10.7

11.2

1.24

222

441

(3008152) Bicarbonate [Moles/volume] in Arterial blood

441

1432

3.52

111.30

8.6

6.8

mmol/l

25.1

24.5

2.29

403

1335

(3016502) Oxygen saturation in Arterial blood

599

2341

3.04

111.12

8.1

7.6

96.4

95.5

3.28

564

2258

(3003396) Base excess in Arterial blood by calculation

643

2625

2.95

110.18

8.1

7.2

mmol/l

1.6

1.1

2.45

509

2051

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

634

2629

2.89

104.99

8.2

7.2

kpa

5.2

5.1

2.39

596

2509

(3027801) Oxygen [Partial pressure] in Arterial blood

634

2630

2.88

104.91

8.2

7.2

kpa

12.6

12.2

1.38

596

2512

(3019060) Gas panel - Arterial blood

437

1529

3.25

96.99

6.5

4.7

—

(3032080) INR in Blood by Coagulation assay

1444

9167

2.35

93.34

8.9

10.0

inr

1.2

1.3

4.23

415

2566

(3013826) Glucose [Moles/volume] in Serum or Plasma

1808

12878

2.43

86.20

6.8

4.8

mmol/l

6.7

6.8

0.59

1724

12095

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

162

300

5.70

83.98

8.6

6.8

mg/l

12.2

11.9

0.36

152

281

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

297

920

3.53

79.38

7.5

5.4

1.9

1.6

4.99

270

861

(3007930) Methemoglobin/Hemoglobin.total in Blood

294

912

3.52

78.37

7.6

5.4

1.0

0.9

3.66

267

856

(3024561) Albumin [Mass/volume] in Serum or Plasma

1432

9742

2.09

69.36

6.7

4.8

g/l

34.0

35.2

11.50

1345

9051

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

183

446

4.35

68.47

2.6

1.6

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1578

11273

2.07

65.10

8.7

6.9

mmol/l

1.2

7.81

1359

9520

(3013707) Erythrocyte sedimentation rate by Westergren method

2026

15968

2.36

64.39

6.2

4.2

mm/h

14.5

13.1

3.90

1906

14723

(3023368) Bacteria identified in Blood by Culture

1011

6195

2.05

63.54

5.4

4.4

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1859

14198

2.18

63.07

6.7

4.7

e6/l

1479.6

2030.4

0.25

211

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1464

10283

2.01

62.01

7.6

6.0

mmol/l

1.2

10.18

1352

9274

(3026008) Bacteria identified in Urine by Culture

1085

6896

2.01

60.86

4.6

3.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1078

6863

2.00

59.92

3.1

2.6

u/l

52.4

58.2

6.18

1025

6319

(3000475) Leukocytes [#/volume] in Synovial fluid

188

544

3.65

55.23

1.8

1.6

e6/l

16558.5

16227.5

0.02

143

388

(3037467) Urinalysis macro (dipstick) panel - Urine

1878

14744

2.07

54.21

6.5

4.5

—

(3019150) Specific gravity of Urine by Refractometry

777

4563

2.02

52.90

5.5

4.3

kg/l

1.0

0.07

139

676

(3007853) Bacteria identified in Skin by Aerobe culture

503

2503

2.26

52.79

2.2

1.7

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

121

265

4.75

51.64

1.9

1.5

55.7

61.3

0.67

170

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

885

5578

1.90

48.00

2.7

2.2

mg/l

2.8

3.0

1.96

782

4733

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2040

16866

2.09

46.12

9.3

7.7

u/l

81.0

79.3

0.68

1968

15870

(3044941) Cell count panel - Synovial fluid

136

364

3.89

44.64

1.8

1.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

729

4416

1.92

43.88

5.1

3.8

ng/l

281.0

353.5

0.25

588

3572

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

411

2031

2.22

43.16

3.8

3.0

ng/l

192.2

208.6

0.35

385

1850

(3035350) Ketones [Presence] in Urine by Test strip

1398

10358

1.78

43.16

5.0

3.8

estimate

0.0

0.00

275

1893

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

490

2595

2.10

43.12

2.2

1.8

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

637

3717

1.95

42.70

2.3

1.8

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1518

11546

1.79

42.59

6.4

umol/l

10.4

11.5

4.72

1458

10960

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

482

2594

2.06

40.37

2.2

1.7

—

(3009261) Glucose [Presence] in Urine by Test strip

1397

10497

1.74

39.64

5.1

3.9

estimate

0.0

1.08

278

1855

(3021788) Differential panel - Synovial fluid

137

405

3.52

38.84

2.0

1.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

1377

10374

1.72

38.06

6.3

5.2

estimate

0.0

0.50

277

1913

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

997

6883

1.74

37.76

2.6

2.1

u/l

195.4

229.7

0.68

948

6437

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

173

613

2.96

36.33

1.5

1.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

981

6828

1.71

35.48

4.0

3.2

u/l

31.5

37.2

1.20

933

6473

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1227

9069

1.69

35.44

2.6

2.2

nmol/l

78.8

78.9

0.03

1121

8070

(3013115) Eosinophils [#/volume] in Blood

1421

10962

1.68

34.48

7.2

6.0

e9/l

0.2

1.66

1314

9549

(3006315) Basophils [#/volume] in Blood

1380

10588

1.67

33.99

7.0

5.8

e9/l

0.0

0.04

1262

9094

(3044640) Blood type and Crossmatch panel - Blood

988

6952

1.69

33.91

3.1

2.4

—

(42870588) Differential panel, method unspecified - Blood

1028

7313

1.68

33.83

7.0

5.8

—

(3044889) 12 lead EKG panel

1848

15359

1.76

33.42

4.9

4.0

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2332

20962

2.49

33.30

26.3

15.4

mg/l

24.1

24.6

0.38

2104

16796

(3006504) Eosinophils/100 leukocytes in Blood

1306

9912

1.66

33.27

7.3

6.0

2.9

2.8

0.35

1229

9210

(3001604) Monocytes [#/volume] in Blood

1372

10546

1.66

33.24

7.0

5.7

e9/l

0.6

1.30

1255

9049

(3019069) Monocytes/100 leukocytes in Blood

1310

9954

1.66

33.19

7.7

6.2

8.5

8.8

2.00

1237

9290

(3019198) Lymphocytes [#/volume] in Blood

1396

10796

1.66

32.87

7.0

5.8

e9/l

1.9

1.00

1286

9436

(3019309) Folate [Moles/volume] in Red Blood Cells

677

4332

1.77

32.48

2.0

1.8

nmol/l

1222.3

1182.3

0.57

555

3253

(3022096) Basophils/100 leukocytes in Blood

1272

9650

1.64

31.96

7.3

6.0

0.6

0.7

2.98

1196

8986

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1085

7931

1.65

31.46

5.4

4.1

—

(3018418) pH of Serum or Plasma

951

6731

1.66

31.24

4.3

4.1

7.4

0.25

174

1280

(3002030) Lymphocytes/100 leukocytes in Blood

1321

10167

1.63

30.93

7.4

6.1

26.9

27.3

0.80

1236

9444

(3018010) Neutrophils/100 leukocytes in Blood

1301

10014

1.62

30.14

7.3

5.9

58.4

57.6

1.49

1221

9344

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

319

1643

2.08

29.46

2.0

1.6

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1158

8713

1.61

29.11

3.2

2.8

ug/l

129.1

138.9

0.90

1085

7985

(3021960) Folate [Moles/volume] in Serum or Plasma

782

5352

1.67

28.71

1.7

1.6

nmol/l

22.3

20.7

0.70

693

4521

(3029937) Albumin [Presence] in Urine by Test strip

813

5625

1.66

28.59

5.9

4.2

estimate

0.0

0.34

267

1840

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1217

9323

1.59

27.97

2.3

2.0

pmol/l

94.4

95.0

0.18

676

4716

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

564

3570

1.75

27.45

1.4

1.3

iu/ml

25.9

38.1

2.13

209

1150

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

712

4826

1.66

26.79

1.9

1.7

pmol/l

36125238.8

30900857.0

0.08

609

3987

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

541

3418

1.74

26.38

1.4

1.2

u/ml

13.3

13.2

0.01

192

1312

(3022948) Iron [Moles/volume] in Serum or Plasma

550

3492

1.74

26.35

2.6

umol/l

11.5

12.8

4.60

518

3228

(3013650) Neutrophils [#/volume] in Blood by Automated count

1523

12393

1.58

26.23

9.6

9.1

e9/l

4.3

4.1

2.39

1403

10798

(3025577) Chromium [Mass/volume] in Blood

142

4.52

25.97

2.1

ug/l

2.0

0.06

123

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

6.87

25.91

1.6

1.3

34.7

25.7

0.65

(3026470) Cobalt [Mass/volume] in Blood

147

4.44

25.77

2.0

2.1

ug/l

3.7

3.1

0.33

128

(3026493) Urate [Moles/volume] in Serum or Plasma

810

5773

1.59

24.42

2.7

umol/l

1824.1

5932.9

3.76

704

4977

(3003458) Phosphate [Moles/volume] in Serum or Plasma

477

2973

1.75

24.18

5.0

5.9

mmol/l

1.1

1.0

1.50

448

2733

(3018677) aPTT in Platelet poor plasma by Coagulation assay

533

3430

1.70

24.06

1.9

2.1

30.1

29.8

0.37

503

3321

(3019550) Sodium [Moles/volume] in Serum or Plasma

2377

21995

2.39

24.01

30.2

17.9

mmol/l

139.4

139.7

5.70

2356

21461

(3004789) Transferrin [Mass/volume] in Serum or Plasma

507

3225

1.72

23.86

2.5

g/l

2.3

0.31

474

2982

(3009508) Creatinine [Moles/volume] in Urine

946

7023

1.56

23.71

3.3

3.2

mmol/l

7.1

7.2

0.12

824

5859

(3023103) Potassium [Moles/volume] in Serum or Plasma

2380

22053

2.40

23.64

30.3

18.0

mmol/l

4.0

7.64

2358

21487

(3036481) Cortisol [Moles/volume] in Serum or Plasma

344

1963

1.87

23.34

2.2

nmol/l

352.1

373.6

1.06

312

1790

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

673

4640

1.61

23.07

1.9

1.8

mg/l

1.4

1.3

0.32

580

3601

(3012095) Magnesium [Moles/volume] in Serum or Plasma

559

3690

1.66

22.76

3.8

3.3

mmol/l

0.8

0.81

522

3438

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

916

6800

1.54

22.71

3.2

3.1

ng/l

1369.2

1461.3

0.30

803

5864

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1103

8576

1.51

21.74

4.8

3.8

ng/l

96.0

56.0

0.27

816

6184

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

475

3037

1.69

21.73

2.7

2.6

20.1

22.6

3.21

345

2587

(3041096) Erythrocytes [Presence] in Urine by Automated

759

5453

1.56

21.55

4.4

3.5

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1858

16156

1.57

21.18

4.4

4.1

pmol/l

14.9

0.18

1721

14577

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

144

620

2.40

20.47

2.3

1.7

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

209

3.47

20.31

1.6

1.3

e6/l

73773.8

62721.0

0.07

147

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

735

5361

1.52

19.02

3.0

2.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2133

19322

1.67

18.95

5.5

4.9

mu/l

1.8

2.1

2.08

1987

17527

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

188

937

2.09

18.74

2.4

2.0

ug/l

2.9

1.9

0.38

167

824

(3002385) Erythrocyte distribution width [Ratio]

1925

17037

1.55

18.68

30.6

18.8

14.0

13.8

11.61

1901

16653

(40761511) CBC panel - Blood by Automated count

2326

21632

1.96

18.50

26.0

14.6

—

(3012516) Albumin [Mass/volume] in Urine

894

6825

1.48

18.40

3.3

3.2

mg/l

1255.4

314.3

2.95

606

4251

(3034891) Synovial lining cells/100 cells in Synovial fluid

104

4.39

18.04

1.6

1.3

3.8

4.8

0.15

(3000494) Fungus identified in Specimen by Culture

399

2555

1.67

17.86

1.8

1.4

—

(3000850) Epithelial cells [#/volume] in Urine

646

4652

1.52

17.50

3.0

2.6

e6/l

5.4

5.5

0.12

589

4078

(3014576) Chloride [Moles/volume] in Serum or Plasma

435

2866

1.63

17.36

8.5

6.7

mmol/l

104.6

104.2

0.92

411

2800

(3014111) Lactate [Moles/volume] in Serum or Plasma

325

1991

1.73

17.11

7.6

6.8

mmol/l

1.3

1.4

0.49

310

1926

(3020191) Ethanol [Moles/volume] in Serum or Plasma

144

3.74

17.11

1.9

1.3

promille

1.1

0.01

110

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

237

1330

1.86

16.75

1.5

—

(3037522) Nuclear Ab [Titer] in Serum

418

2752

1.62

16.68

1.4

1.3

titre

719.0

543.5

0.70

606

(3020682) Albumin/Creatinine [Ratio] in Urine

922

7198

1.44

16.40

3.8

4.0

mg/mmol

10.6

8.6

0.55

606

4455

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

203

3.21

16.32

1.8

1.4

27.9

33.1

0.50

127

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

158

779

2.10

16.20

3.1

2.7

—

(4010399)

266

1584

1.76

15.43

1.5

1.4

—

(3023419) Bacteria identified in Sputum by Culture

302

2.67

14.45

2.2

2.5

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2151

19826

1.58

14.38

6.9

6.1

mmol/mol

40.7

40.2

1.86

2038

18216

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

212

1210

1.82

14.16

9.6

9.3

mmol/l

24.4

0.14

199

1134

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1540

13368

1.39

13.92

3.9

3.2

u/l

55.6

52.3

0.69

1459

12337

(3023520) Reticulocytes [#/volume] in Blood

306

1946

1.65

13.89

2.6

2.5

e9/l

66.6

70.2

1.07

250

1490

(3020779) Urea [Moles/volume] in Serum or Plasma

315

2028

1.63

13.61

5.7

7.8

mmol/l

10.8

10.2

0.59

300

1933

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

108

493

2.24

13.47

1.5

1.4

—

(3020891) Body temperature

171

931

1.90

13.26

5.5

4.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

288

1835

1.64

12.94

3.3

3.8

ng/l

101.3

92.4

0.30

259

1574

(3000991) Gas panel - Venous blood

291

1860

1.64

12.91

9.1

8.3

—

(3022621) pH of Urine by Test strip

238

1450

1.71

12.68

3.9

3.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

578

4304

1.44

12.64

1.3

1.2

u/ml

1.8

1.5

0.21

145

1126

(3011397) Hemoglobin [Presence] in Urine by Test strip

657

5014

1.42

12.54

5.1

3.8

—

(3027945) Reticulocytes/100 erythrocytes in Blood

377

2587

1.54

12.34

2.6

2.5

1.7

1.8

0.88

336

2299

(36660697) Celiac disease serology panel - Serum

248

1539

1.68

12.33

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

132

677

2.00

12.20

1.5

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

359

2459

1.54

11.82

3.0

2.7

umol/l

8.0

8.3

0.09

304

2163

(3026782) Osmolality of Urine

578

4354

1.42

11.76

3.4

2.8

mosm/kgh2o

502.2

542.7

5.51

522

3712

(3002032) Base excess in Venous blood by calculation

313

2084

1.57

11.69

3.7

mmol/l

2.3

1.9

1.17

249

1693

(3015377) Calcium [Moles/volume] in Serum or Plasma

942

7710

1.35

11.55

2.9

3.5

mmol/l

2.3

2.4

2.29

830

6698

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

145

786

1.90

11.41

2.5

2.3

ug/l

570.8

765.8

0.26

137

742

(3022217) INR in Platelet poor plasma by Coagulation assay

428

3068

1.48

11.29

23.4

26.6

inr

1.2

1.4

1.05

423

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

376

2.28

11.03

1.3

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

178

1040

1.77

11.00

1.9

1.7

g/l

1.7

1.6

0.98

146

899

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

321

2180

1.54

10.95

2.0

2.2

g/l

0.2

0.13

296

2039

(3045414) Leukocytes [Presence] in Urine

173

1007

1.77

10.83

2.0

—

(3004588) Protein electrophoresis panel - Serum or Plasma

251

1617

1.61

10.75

2.5

—

(3002582) Erythrocytes [#/volume] in Urine

820

6630

1.35

10.69

4.2

3.3

e6/l

47.6

84.4

1.53

683

5154

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.86

10.66

1.9

1.8

umol/l

96.6

147.3

0.44

(3043409) Potassium [Moles/volume] in Arterial blood

131

705

1.91

10.56

5.5

3.8

mmol/l

3.9

0.26

124

659

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2345

22350

1.70

10.49

14.3

11.0

u/l

25.5

25.7

0.18

2297

21525

(3021447) Carbon dioxide [Partial pressure] in Venous blood

307

2090

1.53

10.34

3.8

3.7

kpa

5.9

5.8

1.10

295

2032

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

292

2.40

10.31

1.6

1.5

—

(3012544) pH of Venous blood

316

2166

1.52

10.31

3.8

3.7

—

7.4

—

(3007461) Platelets [#/volume] in Blood

2400

23037

1.86

10.30

37.2

22.7

e9/l

256.9

249.1

6.59

2372

22421

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

141

784

1.85

10.27

2.9

3.0

u/ml

0.3

0.4

0.11

454

(3024731) MCV [Entitic volume]

2400

23042

1.85

10.22

37.1

22.6

91.6

91.4

1.52

2388

22681

(3035941) MCH [Entitic mass]

2400

23043

1.85

10.21

37.1

22.5

30.4

0.00

2388

22680

(3026361) Erythrocytes [#/volume] in Blood

2400

23045

1.85

10.17

37.2

22.6

e12/l

4.3

4.4

23.58

2368

22352

(3017181) Myelocytes/100 leukocytes in Blood

275

1834

1.56

10.16

4.3

4.1

1.0

0.9

0.21

553

(3010813) Leukocytes [#/volume] in Blood

2400

23047

1.85

10.14

37.3

22.7

e9/l

7.0

6.7

11.39

2369

22359

(3000963) Hemoglobin [Mass/volume] in Blood

2400

23049

1.85

10.11

37.5

22.8

g/l

130.4

134.2

29.75

2387

22692

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

364

2585

1.48

9.99

3.5

4.2

u/l

239.7

247.9

0.63

334

2443

(3020630) Protein [Mass/volume] in Serum or Plasma

287

1941

1.54

9.96

2.5

2.7

g/l

66.0

66.4

0.47

260

1768

(3018095) Leukocytes [#/volume] in Urine

924

7668

1.32

9.90

4.9

3.8

e6/l

94.5

120.5

0.45

723

5518

(3036670) Protein [Mass/volume] in Synovial fluid

3.92

9.85

1.3

1.2

g/l

41.7

37.8

0.65

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2196

20673

1.48

9.77

5.2

4.8

mmol/l

6.1

6.0

1.22

2039

18707

(36304419) Bacteria [Presence] in Urine

731

5884

1.34

9.61

3.9

3.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

727

5853

1.34

9.53

1.8

1.6

mmol/l

1.5

1.4

2.52

635

4879

(3002179) Metamyelocytes/100 leukocytes in Blood

251

1665

1.56

9.49

3.9

0.5

0.6

0.16

395

(3048689) Calprotectin [Mass/mass] in Stool

326

2296

1.48

9.30

1.8

2.2

ug/g

171.8

141.0

0.53

259

1819

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

126

3.05

9.12

1.6

1.4

u/l

4.4

7.0

1.26

105

(1761868) Lipid panel - Serum or Plasma

550

6932

0.74

8.98

2.8

3.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1318

11572

1.29

8.97

2.8

2.6

—

(3025159) Blasts/100 leukocytes in Blood

244

1629

1.55

8.96

4.4

4.2

1.7

0.3

0.39

431

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

152

2.79

8.65

1.3

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

241

2.40

8.59

1.3

1.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

212

1384

1.58

8.59

3.0

3.1

g/l

126.5

127.9

0.40

203

1348

(3017704) Immunofixation for Urine

138

2.85

8.38

1.4

1.7

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

119

672

1.81

8.30

1.5

1.4

ug/g

249.6

281.2

1.11

391

(3026389) Candida sp identified in Specimen by Organism specific culture

264

2.30

8.28

1.8

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

329

2376

1.44

8.22

5.3

3.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

129

2.90

8.17

1.6

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

131

766

1.75

8.13

1.3

1.2

u/ml

0.6

1.0

—

(3052592) Norovirus Ag [Presence] in Stool

4.55

8.12

1.1

1.4

—

(3024263) Appearance of Synovial fluid

119

2.97

8.08

1.7

—

(3023183) Ammonium ion [Moles/volume] in Plasma

484

1.93

8.00

2.3

3.0

umol/l

31.8

36.8

0.87

409

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

131

2.85

7.96

1.6

1.4

—

(3021440) Promyelocytes/100 leukocytes in Blood

251

1740

1.49

7.73

4.4

4.2

0.2

0.1

0.37

506

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

286

2040

1.45

7.62

2.6

2.4

ug/l

4.9

7.1

3.55

254

1789

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1486

0.53

7.46

1.7

1.8

—

(3008898) HLA-B27 [Presence]

105

593

1.80

7.36

1.0

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

499

1.88

7.33

2.4

2.2

g/l

123.1

128.5

1.29

366

(3030467) Casts [#/volume] in Urine by Automated count

733

6088

1.29

7.30

4.0

3.2

e6/l

0.6

0.5

0.49

607

4649

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

102

573

1.81

7.27

2.0

1.8

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

100

560

1.82

7.21

1.8

1.6

—

(3037756) Immunofixation for Serum or Plasma

517

1.85

7.18

1.9

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

355

2.03

7.17

1.7

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

185

1227

1.55

7.02

2.6

2.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

238

2.21

6.61

2.7

1.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

103

599

1.75

6.57

1.9

1.7

—

(3045424) Erythrocytes [Presence] in Urine

374

1.95

6.56

1.5

1.6

—

(44790047)

259

2.15

6.52

1.8

1.5

—

(44806118)

259

2.15

6.52

1.8

1.5

—

(44790049)

259

2.15

6.52

1.8

1.5

—

(44790048)

259

2.15

6.52

1.8

1.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

475

3778

1.32

6.45

1.5

g/l

2.4

2.5

0.29

296

2264

(3003338) MCHC [Mass/volume]

1846

17210

1.27

6.45

34.3

20.0

g/l

331.0

331.8

2.77

1834

17077

(40761535) Cells panel - Urine sediment

262

1898

1.42

6.42

4.1

3.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

544

1.78

6.40

1.8

1.6

—

(3019977) pH of Arterial blood

126

2.64

6.22

3.5

3.0

7.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

132

2.60

6.21

1.5

1.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

361

1.94

6.18

1.1

1.4

—

(4198724)

3.97

6.16

4.1

1.5

—

(21494755) Public health laboratory ask at order entry panel

1389

0.56

6.12

1.2

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

248

1795

1.42

6.11

2.9

2.7

ml/min/173m2

60.8

63.3

0.57

109

730

(3025941) Bacteria identified in Stool by Culture

170

1144

1.52

6.06

1.4

1.2

—

(3011288) Drugs identified in Urine by Screen method

202

2.25

6.02

6.5

2.5

—

(3005719) IgG [Mass/volume] in Serum or Plasma

224

1597

1.44

5.99

2.6

2.8

g/l

9.6

10.5

2.88

202

1453

(40760892) CBC W Ordered Manual Differential panel - Blood

541

4427

1.28

5.89

5.4

4.6

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

159

1062

1.53

5.88

4.5

4.0

mmol/l

24.5

24.1

0.95

136

956

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

105

635

1.68

5.85

1.8

1.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

182

1252

1.49

5.85

2.6

3.3

pmol/l

4.6

4.4

0.80

155

1099

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

406

1.85

5.76

1.8

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

182

1257

1.48

5.74

1.8

g/l

1.1

1.4

2.47

164

1140

(3030981) Hyaline casts [#/volume] in Urine by Automated count

168

1143

1.50

5.70

3.2

2.8

e6/l

0.3

0.31

163

1116

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

315

1.96

5.70

1.7

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

195

1369

1.46

5.66

4.9

3.6

mmol/l

1.9

0.04

146

1016

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

228

2.13

5.62

1.2

u/l

62.4

58.0

0.17

166

(3009015) Lactate [Moles/volume] in Synovial fluid

4.82

5.49

1.3

1.4

mmol/l

5.4

6.0

—

(3009542) Hematocrit [Volume Fraction] of Blood

1968

18602

1.26

5.48

29.0

16.6

38.0

39.3

5.21

1136

12666

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.15

5.46

1.1

—

(3003181) Sodium [Moles/volume] in Urine

444

1.78

5.41

1.5

1.4

mmol/l

63.2

60.7

0.25

359

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

114

724

1.60

5.28

1.6

titre

172.0

217.0

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

160

1096

1.49

5.28

2.8

3.3

mmol/l

25.6

25.3

0.43

153

1060

(3000764) Benzodiazepines [Presence] in Urine

310

1.92

5.27

2.5

1.6

—

(3016879) Cocaine [Presence] in Urine

289

1.96

5.27

2.5

1.7

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

280

2125

1.36

5.20

2.1

1.8

1.7

1.5

2.76

249

1824

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

155

1058

1.50

5.20

2.7

2.6

1.4

1.2

2.46

155

1050

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

974

0.52

5.19

1.3

1.5

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

421

1.78

5.16

1.2

—

294.5

—

(3033658) Prothrombin time (PT) actual/Normal

656

5574

1.24

5.09

5.1

3.9

89.5

88.9

0.24

631

5437

(3028300) Cannabinoids [Presence] in Urine

314

1.90

5.08

2.6

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

411

1.77

4.98

2.3

3.3

—

(3000034) Microalbumin [Mass/volume] in Urine

213

2.08

4.94

3.2

3.0

mg/l

7.9

31.2

1.93

161

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

134

902

1.51

4.83

1.6

1.9

u/l

41.2

38.9

0.65

122

783

(3024354) Oxygen [Partial pressure] in Venous blood

231

1722

1.38

4.81

3.3

2.9

kpa

4.7

4.6

0.22

226

1670

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

347

2751

1.30

4.77

1.4

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

3.59

4.76

1.3

2.0

mmol/l

1.2

0.04

(46235355) HIV 1 and 2 tests - Meaningful Use set

315

2465

1.32

4.76

1.5

1.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.28

4.74

1.1

1.2

—

(3009343) pH of Capillary blood

196

1426

1.41

4.72

4.9

3.6

7.4

0.26

178

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.96

4.71

2.3

2.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.96

4.71

2.3

2.9

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

198

1446

1.40

4.67

4.9

3.6

kpa

5.2

0.58

188

1337

(3044927) Protein electrophoresis panel - Urine

253

1.96

4.64

1.1

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

115

2.45

4.63

1.2

1.1

u/l

23.5

25.3

0.06

(3014051) Protein [Presence] in Urine by Test strip

535

1.65

4.62

2.2

2.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

173

2.16

4.56

1.2

1.5

u/ml

25.8

20.5

—

(3027008) Opiates [Presence] in Urine

312

1.85

4.54

2.5

1.6

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

334

1.82

4.54

1.7

1.9

pmol/l

186.7

202.2

0.66

314

(3001019) Free T4 and TSH panel - Serum or Plasma

864

0.54

4.46

1.9

1.8

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

114

755

1.53

4.45

3.5

3.4

mg/l

40.5

62.9

1.39

626

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2167

20846

1.28

4.44

4.9

4.6

mmol/l

4.5

4.6

4.26

2031

19154

(3017446) Testosterone [Moles/volume] in Serum or Plasma

181

1314

1.41

4.43

2.7

2.2

nmol/l

11.3

12.7

1.59

157

1154

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

114

756

1.53

4.43

3.5

mg/l

29.4

73.7

1.68

628

(3027944) Amphetamines [Presence] in Urine

308

1.84

4.41

2.4

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

125

2.34

4.34

2.2

1.6

—

(40768797) Stomach Pathology biopsy report

386

3140

1.27

4.33

1.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

3.35

4.32

1.7

1.2

mg/l

1.2

110.2

0.49

(3008116) Ketones [Moles/volume] in Urine by Test strip

3.35

4.32

1.6

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

111

737

1.53

4.30

3.5

3.4

ratio

3.0

1.6

0.35

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

609

1.58

4.29

1.5

1.6

iu/ml

1.3

10.2

0.42

119

(3027923) C peptide [Moles/volume] in Serum or Plasma

120

2.35

4.25

1.5

1.3

nmol/l

1.1

1.2

0.07

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

114

2.38

4.23

1.2

1.1

u/l

85.6

79.9

0.18

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

596

1.58

4.21

2.0

2.4

g/l

3.7

3.6

0.29

563

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

244

1876

1.33

4.18

4.4

4.0

mmol/l

1.2

0.24

219

1642

(3010421) pH of Blood

606

1.57

4.16

5.1

4.5

7.4

0.61

503

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2206

21302

1.28

4.14

5.5

5.2

mmol/l

2.6

2.7

9.22

2046

19453

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

481

1.64

4.14

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

481

1.64

4.14

1.4

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

250

1933

1.33

4.12

1.4

1.5

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

146

1034

1.44

4.12

2.7

2.5

0.6

0.7

0.17

138

992

(40760888) Immunoglobulin light chains.free panel - Serum

560

1.59

4.11

3.6

—

(3045716) Anion gap in Serum or Plasma

110

2.38

4.07

5.9

2.5

mmol/l

8.2

9.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

133

928

1.46

4.06

2.2

2.5

g/l

3.8

0.09

668

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

126

870

1.47

4.06

2.1

2.6

g/l

3.2

3.1

0.36

684

(3030313) Adrenal Ab [Titer] in Serum

8.02

4.06

1.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

778

6852

1.20

4.06

5.1

5.0

ug/l

2.4

2.9

0.78

704

6099

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

188

1396

1.37

4.04

1.9

1.7

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

133

929

1.46

4.04

2.2

2.5

g/l

7.6

7.4

0.45

699

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

133

929

1.46

4.04

2.2

2.5

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

423

1.67

4.02

1.3

1.2

u/ml

1.0

4.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

589

1.57

3.97

3.1

mmol/l

24.3

25.0

0.68

506

(3011985) Renin [Units/volume] in Plasma

268

1.84

3.96

1.5

1.4

mu/l

78.2

43.6

0.70

238

(3000012) Reticulocyte production index

112

2.34

3.92

1.6

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2146

20681

1.25

3.91

4.7

4.6

mmol/l

1.4

1.5

3.17

1991

18877

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

588

1.55

3.78

1.6

1.5

g/l

0.2

0.57

557

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

635

5520

1.20

3.78

4.8

4.4

22.5

21.6

0.60

281

2739

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

422

3524

1.24

3.76

3.7

3.0

e6/l

3.4

2.3

1.47

250

1966

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

566

1.56

3.73

1.9

1.6

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

357

1.70

3.68

1.5

1.3

u/l

11.8

11.3

0.11

288

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

143

2.11

3.59

1.7

1.6

u/l

6.0

7.1

0.11

(3028707) Methadone [Presence] in Urine by Screen method

145

2.08

3.47

3.4

2.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

208

1.89

3.44

1.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

252

1.80

3.42

1.1

1.4

pmol/l

281.6

281.4

0.00

190

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.84

3.35

3.9

8.8

—

(3049717) Cytology report of Urine Cyto stain

125

897

1.41

3.34

2.7

2.6

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

2.63

3.30

1.5

1.7

pmol/l

14.0

15.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.93

3.30

4.1

9.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

256

1.77

3.26

3.9

6.3

mmol/l

9.6

7.4

0.35

218

(3005570) Glucose [Moles/volume] in Urine

235

1.80

3.22

1.9

2.1

—

(3028626) Oxygen [Partial pressure] in Capillary blood

514

1.53

3.21

2.8

kpa

8.2

7.9

0.71

468

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

466

1.56

3.21

1.5

1.4

e6/l

181.5

959.1

1.56

376

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

466

1.56

3.21

1.5

1.3

e6/l

20.8

31.2

0.22

357

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

411

1.60

3.19

1.8

1.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

178

1.92

3.19

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

120

864

1.41

3.16

2.3

2.6

g/l

10.1

10.3

0.18

737

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

342

2849

1.23

3.12

10.5

7.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

360

0.41

3.11

1.5

1.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

161

1225

1.34

3.03

1.6

1.3

u/ml

187.8

183.0

0.03

152

1124

(40758558) Short blood count panel - Blood

624

5514

1.17

3.01

7.3

6.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

332

1.64

2.99

1.8

1.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

169

1298

1.32

2.98

1.5

1.3

au/ml

42.8

54.0

—

(3024928) Oxygen saturation in Venous blood

484

1.52

2.95

3.3

2.7

—

(3021901) Oxygen saturation in Capillary blood

428

1.56

2.94

2.7

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

440

3780

1.20

2.94

3.3

2.8

e6/l

1.5

1.2

0.48

263

2205

(3012501) Base excess in Blood by calculation

509

1.51

2.93

5.6

4.8

mmol/l

3.1

2.8

0.27

358

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

192

1.83

2.88

1.5

1.3

u/l

38.7

33.6

0.33

153

(3022689) Creatine [Moles/volume] in Urine

2.60

2.87

1.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.51

2.87

1.9

2.0

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

201

1.80

2.81

1.4

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

201

1.80

2.81

1.4

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

201

1.80

2.81

1.4

1.6

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

3.06

2.81

4.8

8.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

130

2.01

2.80

1.1

1.2

—

(3022145) Colonoscopy Study observation

295

2448

1.23

2.80

1.2

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

246

1.72

2.80

3.2

3.8

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

217

1.76

2.76

3.0

2.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

427

1.54

2.76

1.4

1.7

mu/l

357.3

301.6

0.59

392

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

256

1.69

2.71

1.7

1.8

u/l

741.3

2322.6

0.76

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

160

1.89

2.71

1.6

1.2

mmol/l

2.4

2.2

0.42

149

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

153

1.91

2.70

1.7

1.2

u/ml

0.4

0.6

0.10

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

132

1.98

2.70

1.1

1.2

—

(3037121) Protein [Mass/volume] in Urine

109

796

1.39

2.69

2.6

3.2

g/l

0.3

0.01

306

(44806420)

0.00

2.58

0.0

2.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

237

1.70

2.58

1.5

1.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

260

1.67

2.58

1.1

1.3

nmol/l

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

253

1.67

2.55

1.5

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

324

1.59

2.52

2.0

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

143

1.90

2.51

3.8

2.4

—

(40762814) Titanium [Mass/volume] in Blood

2.83

2.47

2.2

2.3

ug/l

3.0

3.1

—

(3004616) Nuclear Ab [Presence] in Serum

265

1.63

2.41

1.3

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

490

4320

1.17

2.40

2.8

3.1

mmol/l

2.5

0.33

421

3814

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.35

2.38

1.2

1.1

—

(4015189)

2.35

2.38

2.1

2.3

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

183

1.76

2.36

1.3

1.1

—

(3008295) Osmolality of Serum or Plasma

252

1.64

2.34

1.2

1.3

mosm/kgh2o

276.3

277.7

0.15

189

(4281824)

248

0.40

2.32

1.0

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

308

1.57

2.30

1.3

1.7

g/l

0.7

0.9

0.96

236

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

254

2121

1.22

2.30

1.4

1.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

521

1.43

2.29

1.3

1.2

u/ml

12.9

3.9

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

285

1.59

2.28

4.4

5.0

umol/l

320.7

359.1

0.96

248

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

341

1.54

2.27

1.2

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

424

1.47

2.23

3.5

3.6

59.2

58.0

0.31

424

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.10

2.22

3.7

2.3

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

567

1.41

2.21

1.2

1.3

—

19.9

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

100

2.01

2.20

3.2

3.9

—

(3029075) Extractable nuclear Ab panel - Serum

2.41

2.19

1.2

1.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

123

949

1.31

2.18

2.4

1.9

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

297

1.56

2.17

1.1

1.3

nmol/l

0.6

0.4

—

(3021589) Normoblasts [#/volume] in Blood

1002

9327

1.12

2.16

13.6

9.8

e9/l

0.0

1.41

868

7609

(3004446) Plasmodium sp identified in Blood by Light microscopy

4.29

2.15

1.2

2.9

—

(40767503) Oxygen content in Capillary blood by calculation

486

1.43

2.15

2.9

2.5

15.9

16.0

0.09

244

(3050129) First trimester maternal screen panel - Serum or Plasma

151

0.33

2.14

1.6

1.4

—

(3034770) Mitochondria Ab [Titer] in Serum

563

1.40

2.12

1.1

1.2

—

1101.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

532

1.40

2.07

1.3

1.2

u/ml

2.4

7.9

—

(3004451) EKG impression Narrative

117

1.89

2.06

1.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.51

2.05

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

278

1.56

2.03

1.2

1.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.23

2.01

1.2

1.1

—

(40757373) Influenza virus identified in Isolate

2.29

1.97

1.4

1.6

—

(3017732) Neutrophils [#/volume] in Blood

177

1455

1.23

1.90

3.2

3.1

e9/l

3.9

4.1

0.34

139

1105

(4094501)

603

0.66

1.90

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.19

1.88

3.9

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

292

1.52

1.87

2.1

2.3

mg/l

43.8

24.1

0.96

(3004809) Band form neutrophils/100 leukocytes in Blood

374

1.45

1.87

3.0

3.6

0.9

1.4

1.20

293

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

189

1.65

1.87

2.0

1.6

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.86

1.86

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.40

1.85

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

108

1.86

1.81

1.1

iu/ml

7.0

10.7

—

(3004775) Volume in Urine collected for unspecified duration

183

0.44

1.81

4.8

2.1

624.1

654.1

—

121

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.92

1.80

1.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

116

1.82

1.78

1.2

1.3

u/l

174.3

330.7

0.99

106

(3014271) Vancomycin [Susceptibility]

116

1.82

1.78

2.6

3.0

—

(1616796) Gas panel - Central venous blood

497

1.38

1.77

5.3

3.9

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.90

1.75

1.2

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

120

954

1.27

1.75

1.6

1.7

—

(3007566) Smooth muscle Ab [Titer] in Serum

559

1.35

1.73

1.1

1.2

titre

57.5

86.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

499

1.37

1.73

1.5

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

112

885

1.28

1.72

6.1

3.9

mmol/l

24.8

24.9

0.15

105

824

(4062490)

194

1.61

1.71

1.3

1.5

—

(3020491) Glucose [Moles/volume] in Blood

157

1.66

1.65

2.5

2.1

mmol/l

7.2

7.0

0.16

100

(3042631) Mycobacterium sp identified in Specimen

318

1.45

1.64

2.1

2.6

—

(4133840)

2.21

1.57

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

634

0.70

1.55

1.2

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

100

1.81

1.53

1.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.34

1.52

1.2

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

108

865

1.26

1.51

2.3

1.8

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2045

19986

1.12

1.50

4.2

4.1

mmol/l

1.4

1.3

8.10

1894

18093

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

392

1.39

1.50

2.0

1.2

u/l

35.4

37.4

0.06

336

(3024891) Influenza virus A+B Ag [Presence] in Specimen

513

1.33

1.49

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.01

1.48

1.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.81

1.47

1.5

2.6

u/ml

700.8

1298.6

1.25

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

260

1.47

1.46

2.0

1.6

—

(3036489) Thrombin time

747

1.27

1.42

1.8

2.0

20.3

21.5

2.69

663

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

136

0.44

1.40

1.2

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

296

1.43

1.39

1.7

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

111

1.72

1.39

1.0

1.6

umol/l

4.2

12.9

0.82

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

129

1066

1.22

1.39

1.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

147

1231

1.21

1.38

1.2

1.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.08

1.38

3.5

2.7

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

142

1.63

1.38

1.1

1.3

—

73.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.95

1.38

1.3

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

360

3994

0.88

1.37

3.3

3.1

ug/l

0.7

0.8

1.05

237

2695

(3024139) IgG subclass 3 [Mass/volume] in Serum

190

1.53

1.37

1.3

1.5

g/l

0.3

0.4

0.74

131

(3028192) IgG subclass 2 [Mass/volume] in Serum

190

1.53

1.37

1.3

1.5

g/l

2.4

2.9

0.76

132

(3027135) IgG subclass 1 [Mass/volume] in Serum

190

1.53

1.37

1.3

1.5

g/l

5.9

7.0

1.16

132

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

175

1.55

1.34

1.2

1.1

—

56.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.04

1.32

1.0

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

291

1.42

1.32

1.7

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

630

1.28

1.32

1.4

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

150

1266

1.20

1.31

1.2

iu/ml

123.7

154.0

0.43

468

(3006462) Nitrate [Presence] in Urine

1.74

1.31

4.2

4.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

234

1.46

1.29

3.1

3.5

61.1

55.9

0.63

153

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.78

1.28

1.0

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.78

1.28

1.2

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

293

1.41

1.28

1.7

1.4

—

(3022313) Gas panel - Capillary blood

125

1040

1.21

1.28

5.6

3.7

—

(3052851) Hemolysis interference index of Serum or Plasma

696

1.26

1.27

4.2

3.6

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.74

1.25

3.3

2.6

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.40

1.24

1.0

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.86

1.24

1.2

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

637

1.26

1.23

1.4

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.63

1.21

1.6

1.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.63

1.21

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.63

1.21

1.2

1.0

—

(3019174) dRVVT (LA screen)

2.63

1.21

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

288

1.40

1.21

1.8

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

288

1.40

1.21

1.8

1.4

—

(3001186) Copper [Moles/volume] in Serum or Plasma

2.17

1.21

1.0

umol/l

14.9

17.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.17

1.21

2.0

1.9

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

116

1.64

1.21

2.5

1.8

u/field

1.4

2.3

0.69

(3044242) Glucose [Moles/volume] in Arterial blood

124

1.62

1.20

3.4

2.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.84

1.19

1.2

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.88

1.18

1.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

290

1.39

1.17

1.8

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

642

1.25

1.16

1.4

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

129

0.46

1.16

1.2

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

129

0.46

1.16

1.2

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

130

0.46

1.15

1.2

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

130

0.46

1.15

1.2

1.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

430

1.31

1.15

5.7

5.3

iu/ml

694.1

382.7

0.29

(3044290) Cell count panel - Cerebral spinal fluid

430

1.31

1.15

1.4

1.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

229

2027

1.14

1.13

2.8

2.4

u/l

32.7

39.5

1.28

188

1739

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

555

1.27

1.13

1.9

2.4

208.3

196.0

0.50

530

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

276

1.38

1.11

1.1

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

692

1.24

1.10

2.4

g/l

0.0

1.17

639

(44816559) Phosphatidylethanol [Mass/volume] in Blood

320

1.35

1.09

1.4

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

104

1.64

1.09

2.4

2.7

109.4

98.2

1.19

(3016750) Collection duration of Urine

139

0.50

1.09

4.9

2.0

min

459.3

496.8

—

101

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.95

1.08

1.5

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

128

1.57

1.08

2.2

2.7

47.9

39.6

—

(4035726)

177

2022

0.87

1.08

1.3

1.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1965

20025

0.92

1.08

21.7

14.4

ml/min/173m2

77.9

77.4

0.53

1671

16611

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.69

1.07

1.7

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

202

1.44

1.07

1.1

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.65

1.06

1.3

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.65

1.06

1.3

1.8

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

691

0.78

1.06

1.6

1.7

mg/l

6.1

3.9

0.45

502

(3016018) Differential panel - Cerebral spinal fluid

211

1.43

1.06

1.3

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

192

0.57

1.05

1.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

121

1.57

1.05

1.3

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

121

1.57

1.05

1.3

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

121

1.57

1.05

1.3

1.7

—

(3023199) Leukocytes [#/volume] in Pleural fluid

306

1.35

1.03

1.3

1.4

e6/l

1868.5

1769.8

0.06

224

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

187

1.45

1.03

3.6

4.9

u/ml

90.5

51.2

—

(3035880) pH of Pleural fluid

138

1.53

1.02

1.1

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

188

1.44

1.01

2.1

1.6

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

147

1.50

1.00

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

147

1.50

1.00

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

109

0.46

1.00

1.0

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.62

1.00

1.3

1.8

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

793

1.21

0.99

2.6

g/l

0.5

1.1

1.30

690

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

148

1.49

0.98

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.95

0.97

1.3

ng/l

80.0

100.9

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

258

1.36

0.97

3.3

4.1

—

(3051593) INR in Capillary blood by Coagulation assay

116

1.56

0.96

10.6

12.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

242

1.37

0.94

2.7

2.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.77

0.94

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.77

0.94

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.77

0.94

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.77

0.94

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.23

0.93

1.2

1.0

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

150

1.47

0.93

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

150

1.47

0.93

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

150

1.47

0.93

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

491

1.25

0.91

1.1

—

(4146454)

270

1.34

0.90

2.6

2.7

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

728

1.20

0.90

2.3

2.4

g/l

37.2

37.5

0.15

627

(4211845)

110

1.55

0.90

4.2

3.8

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.75

0.90

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.91

0.88

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

494

1.24

0.87

1.4

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

103

1.56

0.87

1.5

1.7

—

(3002619) Bacteria identified in Specimen by Culture

1.86

0.87

1.1

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.00

0.87

1.2

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.00

0.87

1.0

—

(3025130) Human papilloma virus identified in Specimen

192

0.62

0.86

1.6

1.9

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

128

1.49

0.86

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

228

0.66

0.86

1.4

1.5

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

204

1.38

0.85

3.0

2.1

—

(3028433) Virus identified in Specimen by Culture

1.63

0.84

1.4

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.94

0.84

1.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.94

0.84

1.0

2.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.57

0.84

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.78

0.84

1.1

1.0

—

(3000330) Specific gravity of Urine by Test strip

134

1173

1.15

0.83

2.9

3.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

121

1.49

0.82

1.2

1.7

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

399

1.26

0.82

2.1

1.6

—

(40768443) Skin Pathology biopsy report

114

987

1.16

0.82

1.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

138

1.45

0.81

1.2

1.0

mg/l

253.3

292.3

0.50

118

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.73

0.79

1.1

1.4

98.4

84.9

—

(4212803)

0.00

0.79

0.0

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

0.79

0.0

1.5

—

8.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

304

0.72

0.78

2.1

2.3

u/ml

7.6

911.0

0.54

295

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

165

1.40

0.77

1.1

1.0

ng/l

777.9

673.4

0.62

104

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

1.70

0.75

1.1

1.2

113.1

98.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.70

0.75

1.1

92.2

86.5

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

1.60

0.75

2.3

1.5

umol/l

2.0

0.04

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.09

0.74

1.0

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

167

1.38

0.73

1.1

1.0

ng/l

26.5

45.3

2.84

104

(3006653) Thiamine [Moles/volume] in Blood

108

1.48

0.73

1.1

1.2

nmol/l

136.6

138.4

0.05

108

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

379

1.24

0.73

1.5

1.6

—

(1002224) Polysomnography panel

731

0.83

0.73

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.00

0.72

1.0

1.1

—

(3005033) Fetal Nuchal fold Thickness US

106

0.57

0.72

1.2

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

107

0.56

0.72

1.2

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

110

0.54

0.72

1.2

1.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

600

1.19

0.71

1.8

2.1

93.3

89.7

0.59

563

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

101

1.49

0.70

1.6

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

101

1.49

0.70

1.6

1.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

143

1.40

0.70

1.2

1.1

mg/l

36.5

43.3

0.45

121

(3023511) Choriogonadotropin [Units/volume] in Urine

143

1.40

0.70

1.5

1.3

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.71

0.70

1.1

—

6.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.85

0.68

1.2

1.0

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

1.67

0.68

1.1

2.4

—

35.3

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.54

0.67

13.4

12.6

nmol/l

684.6

836.5

—

(40768800) Prostate Pathology biopsy report

429

0.79

0.67

1.1

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

119

1.43

0.67

1.1

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

119

1.43

0.67

1.1

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.51

0.66

1.1

1.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

849

1.15

0.64

2.4

3.4

u/ml

84.8

4958.3

0.85

716

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

591

0.83

0.64

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

137

1.39

0.64

1.5

1.9

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

120

1.42

0.64

1.1

—

(3045788) Cell count panel - Pleural fluid

242

1.28

0.64

1.3

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

542

1.19

0.64

2.9

2.3

ug/min

80.5

105.8

0.32

333

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.73

0.64

1.2

1.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.73

0.64

2.2

1.8

umol/l

60.0

46.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

488

1.19

0.63

1.2

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

297

1.25

0.62

1.2

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

480

1.19

0.61

1.5

1.7

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.67

0.61

2.4

2.2

umol/l

11.4

20.1

—

(40768793) Breast Pathology biopsy report

522

0.82

0.61

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.60

0.61

1.3

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

156

1414

1.11

0.60

1.2

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

165

1.34

0.60

1.1

1.0

ng/l

211.6

309.7

2.35

105

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.00

0.58

0.0

2.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

139

1256

1.11

0.58

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

530

1.17

0.57

3.4

3.1

nmol/l

0.8

0.22

403

(3003694) ABO and Rh group [Type] in Blood

566

5415

1.06

0.57

1.4

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

746

1.14

0.56

1.7

1.6

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.58

0.56

1.4

1.5

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.62

0.55

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

183

0.71

0.55

1.6

1.7

—

(40768441) Liver Pathology biopsy report

159

1.32

0.55

1.6

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

133

1.36

0.55

2.2

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

133

1.36

0.55

2.2

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

330

1.22

0.54

1.2

1.4

u/ml

124.2

120.5

—

(40768804) Tissue Pathology biopsy report

859

8863

0.95

0.54

2.3

2.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

116

1.38

0.54

1.1

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.50

0.54

1.4

2.1

—

(40768806) Pleura Pathology biopsy report

250

0.76

0.54

1.8

1.6

—

(3009871) Measles virus Ab [Titer] in Serum

1.48

0.53

1.8

1.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

377

1.20

0.53

1.1

1.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.54

0.53

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

563

1.16

0.53

4.0

3.2

mg/l

1.7

1.6

0.20

513

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

648

1.15

0.52

2.6

2.5

g/l

0.0

0.00

597

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

132

0.68

0.52

1.0

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

227

2115

1.08

0.51

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

197

1.27

0.51

1.2

1.1

—

(3047189) Immunofixation for 24 hour Urine

118

1.36

0.50

2.9

1.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

270

1.23

0.50

1.3

1.4

e6/l

28517.4

84174.8

0.99

157

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.56

0.49

1.1

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

108

0.65

0.48

1.3

1.5

—

(4024509)

235

1.24

0.48

1.4

1.7

—

(3011412) CD3 cells [#/volume] in Blood

191

1.26

0.46

1.5

2.0

e9/l

1.0

1.1

0.20

118

(40768795) Lymph node Pathology biopsy report

210

0.76

0.46

1.1

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

267

2830

0.94

0.45

5.0

4.7

31.1

33.0

2.10

192

1860

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

265

2498

1.07

0.45

2.8

4.1

ug/l

48.2

18.2

0.43

223

2044

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

428

0.84

0.45

1.2

1.3

miu/ml

148.1

210.3

—

178

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

242

0.78

0.44

1.1

1.0

u/ml

2.4

2.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

275

0.80

0.44

2.0

2.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

104

943

1.11

0.44

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

130

1.31

0.44

5.1

6.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

139

1.30

0.43

1.8

2.1

e6/l

776.9

699.8

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.61

0.43

1.2

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.61

0.43

1.8

1.7

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.56

0.42

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

478

0.86

0.42

4.0

3.9

mg/l

26.1

26.7

0.04

304

(3024316) Viscosity of Plasma

0.00

0.41

0.0

1.5

—

1.9

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

0.00

0.41

0.0

1.7

—

14.3

—

(3017569) Oxygen content in Arterial blood

114

1.32

0.40

4.0

2.5

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

132

1.29

0.40

1.6

1.2

mmol/l

14.1

11.9

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

206

1.22

0.38

1.1

1.3

—

(3000492) Spirometry study

183

1948

0.93

0.37

1.6

1.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.31

0.37

1.1

miu/ml

1658.8

1612.7

—

(3048879) Bone marrow aspiration report

1.29

0.36

1.3

1.7

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

337

1.16

0.36

1.1

1.2

u/ml

282.9

280.3

0.02

199

(3011648) Oxygen content in Venous blood

189

1.22

0.36

1.9

1.7

10.3

11.2

0.40

189

(3032773) Endomysium IgG Ab [Titer] in Serum

157

0.76

0.35

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.33

0.35

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.43

0.35

1.2

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.63

0.35

1.0

1.5

—

(4027681)

108

1.30

0.35

1.4

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

642

1.11

0.34

2.6

2.5

g/l

0.0

0.00

596

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

172

1.22

0.34

1.1

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

584

0.89

0.34

3.9

4.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.33

0.33

1.0

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.32

0.33

1.0

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

155

1.23

0.32

1.8

1.5

umol/l

12.0

13.2

0.57

146

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

128

1.25

0.32

1.3

1.1

—

(3013512) EKG study

684

6672

1.03

0.31

4.4

4.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

262

0.84

0.31

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

156

1.22

0.31

2.1

1.5

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

107

0.75

0.29

1.6

1.3

mmol/l

5.8

6.2

—

100

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

139

1.22

0.29

1.5

2.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

110

0.73

0.28

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

121

1.24

0.28

1.2

1.1

—

(40761536) Microorganisms panel - Urine sediment

185

1761

1.05

0.27

6.0

4.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.25

0.27

1.0

1.9

ug/l

0.6

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.25

0.27

1.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

553

0.90

0.27

1.4

1.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

172

0.81

0.27

1.2

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.19

0.26

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.26

0.26

1.9

1.3

—

(40768446) Kidney Pathology biopsy report

0.68

0.26

1.4

1.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

169

1.18

0.25

1.0

1.1

u/ml

1.4

3.7

0.94

(3024869) Neuronal Ab [Presence] in Serum

1.32

0.23

1.4

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.75

0.22

1.0

1.2

—

(3002256) Pathology report gross observation

274

2832

0.96

0.22

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

865

1.07

0.22

1.2

1.4

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.21

0.0

1.6

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

0.00

0.21

0.0

1.3

—

0.4

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.21

0.0

6.0

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.4

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

5.0

—

394.2

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.21

0.0

3.0

—

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

5.7

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.21

0.0

1.3

—

5783.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

6.4

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.21

0.0

4.4

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

0.00

0.21

0.0

1.4

—

16.6

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.6

—

23.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

272

0.88

0.20

1.1

u/ml

0.6

1.5

1.06

106

(4034850)

722

1.07

0.20

13.8

10.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.20

0.0

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

115

0.78

0.20

1.1

1.4

—

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

176

0.85

0.20

1.2

—

(3036603) Volume of Urine

146

1.17

0.19

1.9

1.4

2250.0

1841.6

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

146

1.17

0.19

2.4

1.5

g/l

0.9

1.0

0.23

146

(3014133) Dog dander IgE Ab [Units/volume] in Serum

184

1.14

0.19

1.0

u/ml

3.2

2.9

0.03

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.19

0.18

2.0

1.3

ug/l

9.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

1.19

0.18

1.3

2.9

172.4

188.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.17

0.17

1.3

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

119

1.18

0.17

3.9

3.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

195

1.13

0.17

2.5

2.1

u/field

2.2

0.02

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

158

1.14

0.16

1.0

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

183

0.87

0.16

1.3

1.4

nmol/l

0.2

0.3

0.17

134

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

312

1.09

0.15

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

290

2969

0.97

0.15

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

101

968

1.05

0.14

1.0

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.19

0.14

1.1

1.2

iu/ml

287.7

229.8

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.19

0.14

1.5

2.3

—

28340.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

363

1.08

0.14

1.0

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

113

1.15

0.13

1.2

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

113

1.15

0.13

1.2

1.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

209

1.10

0.13

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

306

1.08

0.13

1.1

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

511

1.06

0.12

1.7

1.9

iu/l

5.9

4.8

0.19

162

(4306422)

259

1.08

0.11

1.2

—

(3023410) Appearance of Cerebral spinal fluid

211

1.09

0.11

1.6

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

318

1.07

0.11

1.2

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

115

0.87

0.10

1.2

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

125

0.88

0.10

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

486

1.05

0.10

1.1

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

269

0.93

0.10

1.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.04

0.09

1.2

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

184

1.09

0.09

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

194

1.08

0.09

1.3

nmol/l

1.4

1.5

0.29

172

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.09

0.09

1.0

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.09

0.09

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

243

1.07

0.08

1.3

mmol/l

7.3

7.5

0.10

176

(3034426) Prothrombin time (PT)

1.07

0.08

1.2

1.3

—

(3051651) Icteric interference index of Serum or Plasma

144

0.90

0.08

3.6

3.9

—

(3020650) Glucose [Presence] in Urine

0.83

0.08

1.0

1.8

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

146

1.10

0.08

1.5

2.0

16.5

14.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

287

0.94

0.08

1.1

—

13.2

—

(3045142) Bone marrow Pathology biopsy report

254

1.06

0.07

1.1

1.3

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

0.86

0.07

1.8

1.6

—

(3015183) Erythrocyte sedimentation rate

1.03

0.07

1.0

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

0.82

0.07

1.7

1.8

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

226

1.06

0.06

1.2

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

183

0.93

0.06

2.2

2.4

—

(3012441) Differential panel - Pleural fluid

253

0.95

0.05

1.4

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

614

1.03

0.05

1.6

1.3

iu/l

31.0

35.4

0.52

525

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

110

1.09

0.05

2.2

2.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

150

0.93

0.04

1.0

1.3

—

(3019225) pH of Specimen

239

2368

1.01

0.04

4.7

4.4

—

(3051611) Lipemic interference index of Serum or Plasma

251

0.96

0.04

3.1

3.6

—

(44813793)

129

0.93

0.03

1.2

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

152

1.05

0.02

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

258

0.97

0.02

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

502

1.02

0.01

2.0

3.2

u/ml

40.2

842.0

0.93

466

(3010726) Horse dander IgE Ab [Units/volume] in Serum

207

0.97

0.01

1.1

1.0

u/ml

0.7

2.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

253

1.03

0.01

1.0

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

225

0.98

0.00

1.0

u/ml

1.0

1.8

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

275

1.02

0.00

1.2

u/ml

12.4

3.4

—

(21494434) Karyotype in Bone marrow

219

1.00

0.00

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

231

1.00

0.00

1.0

u/ml

4.2

4.7

0.05

105

(4268621)

186

1.02

0.00

2.1

2.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.02

0.00

1.2

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

444

0.99

0.00

1.4

1.8

nmol/l

0.9

0.8

0.32

364

(3003740) Influenza virus B Ag [Presence] in Specimen

252

0.99

0.00

1.0

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

267

1.01

0.00

1.3

1.2

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

15.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.99

0.00

1.3

1.4

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3044007) Cell count panel - Peritoneal fluid

0.87

0.00

1.5

2.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.88

0.00

2.2

1.5

—

(3042733) HLA Ab [Presence] in Serum

0.85

0.00

1.0

4.7

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

0.93

0.00

2.2

2.8

—

(3035933) Granulocytes/100 leukocytes in Blood

0.91

0.00

1.2

2.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.0

—

1.4

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

270

1.00

0.00

1.3

1.2

u/ml

4.9

5.2

0.06

116

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

2.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.94

0.00

1.1

1.3

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

3.0

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

2.8

—

3.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1745.2

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

0.0

2.0

—

716.5

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

8.0

—

74.8

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.7

—

2.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.91

0.00

1.2

1.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_POSTOPMUSCULOSKE and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_POSTOPMUSCULOSKE	1.476 [1.29, 1.69]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.329

During the follow-up period (1.1.1998 — 31.12.2019), 1446 out of 6530 females with M13_POSTOPMUSCULOSKE died.

Males

Parameter	HR [95% CI]	p-value
M13_POSTOPMUSCULOSKE	1.321 [1.13, 1.54]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.019

During the follow-up period (1.1.1998 — 31.12.2019), 891 out of 4176 males with M13_POSTOPMUSCULOSKE died.

Mortality risk

Mortality risk for people of age

years, who have M13_POSTOPMUSCULOSKE.

N-year risk	Females	Males
1	0.166%	0.264%
5	0.762%	1.623%
10	2.021%	4.192%
15	4.241%	7.917%
20	7.035%	13.441%

Relationships between endpoints

↥

Index endpoint: M13_POSTOPMUSCULOSKE – Postprocedural musculoskeletal disorders, not elsewhere classified

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Postprocedural musculoskeletal disorders, not elsewhere classified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints